One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2019-122576
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 19 |
Affiliation: Seagen (United States), Sylvester Comprehensive Cancer Center, Dana-Farber Cancer Institute, University of Nebraska Medical Center, City Of Hope National Medical Center, Mayo Clinic, Hackensack University Medical Center, Karmanos Cancer Institute, Stanford Medicine, Bristol-Myers Squibb (United States), Washington University in St. Louis, James Cancer Hospital, Memorial Sloan Kettering Cancer CenterBrentuximab Vedotin and Nivolumab for Relapsed or Refractory Classic Hodgkin Lymphoma: Long-Term Follow-up Results from the Single-Arm Phase 1/2 Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
